April 7, 2022
There’s more than one way to architect a decentralized clinical trial (DCT). While this flexible model has many benefits, it can be overwhelming to bring together all the right elements to operationalize a trial that’s predominantly digital. Every trial is unique, so it is not realistic to templatize (impose a standard implementation template on) a DCT. But four common, fundamental components combine to facilitate a seamless, patient-centric DCT.
“It’s like a trial in a box, but each box is a little bit different,” said Steve Rosenberg, CEO of a cloud-based platform company that powers decentralized clinical trials. Even with a DCT’s inherent optionality, foundational components can ease implementation and improve execution.
SALT LAKE CITY, April 6, 2022 — Curavit Clinical Research, the first virtual contract research organization (VCRO), announced that it was recently named runner up in the 2022 Wilson Sonsini Entrepreneur & Investor Life Sciences Summit (E&I Summit) pitch competition, sponsored by Morgan Stanley. Curavit received the award for its innovative business model and ‘digital first’ approach to democratizing clinical research.
Now in its 7th year, the E&I Summit, presented by BioUtah, BioHive and the PIVOT Center, attracted a record setting 300+ registrants, along with an impressive line-up of distinguished speakers, national and local investors, and numerous Utah life sciences startups.
“We are so happy to be recognized in this capacity by our industry peers and to have had the opportunity to share what we are doing at Curavit,” said Dave Hanaman, Co-founder, President and Chief Commercial Officer of Curavit. “It was an honor to be able to share the stage with so many inspiring companies. Our satisfaction of being recognized by the judges was only overshadowed by the exciting ability to engage with so many innovative entrepreneurs and investors in the dynamic Utah ecosystem.”
The conference featured notable keynote speakers, including Jake Manoukian, Head of Investment Strategy for JP Morgan, who shared insights on market trends and life sciences investment, and Stanford University professor Matt Vassar, who provided a thought-provoking address on “Telling Your Story.”
Out of a total of 21 life sciences companies, Curavit advanced to the popular Pitch Track session through a competitive selection process and went on to win second place after Eliksa Therapeutics.
For being named runner-up in the competition, Curavit was refunded its $1,000 registration fee, which the company donated to BioHive, an organization launched last year to brand, build and bring together the life sciences and healthcare innovation industry in Utah. The funds will be used to support local underrepresented communities, aligned with industry partners to promote K-12 STEM education, workforce development and awareness.
“We are thrilled Curavit sees the value in what we’re doing at BioHive to tell the story of our industry and unite all of the stakeholders for life sciences and healthcare innovation in Utah,” said Katelin Roberts, Executive Director at BioHive. “Their organization works at the nexus of patients, research and industry. Similarly, BioHive seeks to be the hub for our community, and their donation will go toward building our state into a premier life sciences and healthcare innovation ecosystem.”
About Curavit
Curavit Clinical Research is a Virtual Contract Resource Organization (VCRO) that designs and executes Decentralized Clinical Trials (DCT) from digital first principles. Curavit leverages emerging technologies in digital health, cloud computing, and data science to recruit, engage, and monitor diverse patient populations without borders, eliminating the need for physical infrastructure and travel while increasing data quality. Curavit brings together the world’s leading researchers, enrolls previously underserved patient populations, and applies machine learning to health and social engagement information to recruit participants. The company’s cloud-based, central virtual site is always audit ready. For more, visit www.curavitclinicalresearch.com
About BioUtah
BioUtah is an independent 501(c)(6) trade association serving Utah’s life sciences industry. Its member companies reflect a broad spectrum of the industry with strengths in medical device manufacturing and services, research and testing, biotechnology, biopharmaceuticals, advanced diagnostics, and healthIT, amongst others; and are a key driver of Utah’s economy and life-saving treatments and cures for patients. BioHive is a chartered organization of BioUtah. Its mission is to brand, build and bring together Utah’s life sciences and healthcare innovation community. For more, visit https://bioutah.org/.
Media Contacts:
Jamie Dabao Brown, +1 (626) 488-0732, jamie@barbadoraink.com
Lisa Barbadora, +1 (610) 420-3413, lbarbadora@barbadoraink.com
